Abstract
This is a case report of a 62-years-old male who developed neurological symptoms consistent with Guillain-Barre Syndrome following a hospital admission for Covid-19. As a new condition we feel there are learning points to be gained for clinicians managing patients recovering from Covid-19 and discuss the symptoms, signs, and management taken in this case. The patient thankfully made a full recovery, but his case is discussed in the context of other cases in the literature. We feel that this case is different and notable as it had a longer latent period between Covid-19 resolution and Guillain-Barre Syndrome onset than any other cases reported.
References
NHS (2020) Overview: Guillain-Barré syndrome. Available at: https://www.nhs.uk/conditions/guillain-barre-syndrome/ (accessed 23.10.2020).
Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurology 2020;19(5):383- 384. Available from: https://doi.org/10.1016/S1474-4422(20)30109-5
Brasil P, Sequira PC, Freitas AD, Zogbi HE, Calvet GA, De Souza RV. Guillain-Barre syndrome associated with Zika virus infection. Lancet 2016;387(10026):1482. Available from: https://doi.org/10.1016/S0140-6736(16)30058-7
Toscano G, Palmerini F, Ravaglia S et al. Guillain-Barre Syndrome associated with SARS-CoV-2. New England Journal of Medicine 2020;382:2574-2576. Available from: https://doi.org/10.1056/ NEJMc2009191.
Kim JE, Heo JH, Kim HO et al. Neurological complications during treatment of Middle East Respiratory Syndrome. Journal Clinical Neurology 2017;13(3):227-233. Available from: https://doi.org/10.3988/jcn.2017.13.3.227
Alberti P, Beretta S, Piatti M et al. Guillain-Barré syndrome related to COVID-19 infection. American Academy of Neurology. 2020;7(4). Available from: https://doi.org/10.1212/NXI.0000000000000741